Elicio Therapeutics (ELTX) Cash & Equivalents Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | -18.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.54% |
| Dec 31, 2025 | 5.36% |
| Sep 30, 2025 | -20.78% |
| Jun 30, 2025 | 544.91% |
| Mar 31, 2025 | 54.82% |
| Dec 31, 2024 | 36.64% |
| Sep 30, 2024 | 75.30% |
| Jun 30, 2024 | -84.20% |
| Mar 31, 2024 | 38.28% |
| Dec 31, 2023 | 109.45% |
| Sep 30, 2023 | 707.01% |
| Jun 30, 2023 | 3,525.75% |
| Mar 31, 2023 | -88.26% |
| Dec 31, 2022 | -93.06% |
| Sep 30, 2022 | -98.21% |
| Jun 30, 2022 | -99.49% |
| Mar 31, 2022 | -44.04% |
| Dec 31, 2021 | 156.47% |